Literature DB >> 8393221

Recent advances in the treatment of visceral leishmaniasis.

R N Davidson1, S L Croft.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8393221     DOI： 10.1016/0035-9203(93)90457-2

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN： 0035-9203            Impact factor:   2.184


× No keyword cloud information.
  3 in total

1.  In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis.

Authors:  F Faraut-Gambarelli; R Piarroux; M Deniau; B Giusiano; P Marty; G Michel; B Faugère; H Dumon
Journal:  Antimicrob Agents Chemother       Date:  1997-04       Impact factor: 5.191

Review 2.  Human antiprotozoal therapy: past, present, and future.

Authors:  M Khaw; C B Panosian
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

3.  Ribosomes of Leishmania are a target for the aminoglycosides.

Authors:  M Maarouf; F Lawrence; S L Croft; M Robert-Gero
Journal:  Parasitol Res       Date:  1995       Impact factor: 2.289
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.